ARCHIVES

Afinitor Tablet Doubles PFS; Lowers Progression Risk 65%

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Drug Development Program Produced 7 Drugs In 10 Years, Chabner Tells Group

February 3, 1995

Conte Withdraws Amendments Adding $40 Million for Flood Promise To Compromise

June 24, 1977

Scientists Brief Writers On Progress In Cancer Research

April 11, 1975

Neulasta Reduces Incidence Of Febrile Neutropenia

February 22, 2013

Neutron Clinical Trials Contract Concept Approved

June 22, 1984

In Brief: DOD Bill includes $135M For breast Cancer, $45M For prostate Cancer Technologies

October 3, 1997